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Abstract 20 
Flavonoids are distributed across the plant kingdom and have attracted 21 
substantial attention owing to their potential benefits for human health. 22 
Several studies have demonstrated that flavonoids prenylation enhances 23 
various biological activities, suggesting an attractive tool for developing 24 
functional foods. This review provides an overview of the current knowledge 25 
on how prenylation influences the biological activity and bioavailability of 26 
flavonoids. The enhancement effect of prenylation on the biological activities 27 
of dietary flavonoids in mammals was demonstrated by comparing the effect 28 
of 8-prenyl naringenin (8PN) with that of parent naringenin in the 29 
prevention of disuse muscle atrophy in mice. This enhancement results from 30 
higher muscular accumulation of 8PN than naringenin. As to bioavailability, 31 
despite the lower absorption of 8-prenyl quercetin (8PQ) compared with 32 
quercetin, higher 8PQ accumulation was found in the liver and kidney. These 33 
data imply that prenylation interferes with the elimination of flavonoids 34 
from tissues.  35 
 36 
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 40 
I. Introduction 41 
Flavonoids, which have a diphenyl propane structure, are synthesized as 42 
plant secondary metabolites. The prenyl group, C5 isoprene (dimethylallyl) 43 
unit(s), binds to different positions of the aromatic ring of flavonoids through 44 
the action of prenyl transferase 1. These flavonoids are predominantly 45 
C-prenylated, whereas a few studies have shown O-prenylated substituents 2. 46 
More than 1000 species of prenyl flavonoids were isolated and identified 47 
from plants classified as leguminous, moraceous, and others 2. Some of these 48 
plants are used as food ingredients or in traditional Oriental medicines. 49 
Prenyltransferases are cloned from edible plants, including Humulus 50 
lupulus (hops), Glycine max (soy bean), Citrus limon (lemon), and Lupinus 51 
albus (lupine) 3-6. Xanthohumol (XN; 52 
2',4,4'-trihydroxy-6'-methoxy-3'-prenylchalcone, Fig. 1), isoxanthohumol (IX, 53 
Fig. 1), 6-prenyl naringenin (6PN, Fig. 1), and 8-prenyl naringenin (8PN, Fig. 54 
1) are found in hops, a key ingredient of beer 7. 8-Prenyl quercetin (8PQ, Fig. 55 
1) was found in Desmodium caudatum 8, which acts as a preservative for food 56 
storage. Koeduka et al. 9 and Sugiyama et al. 10 developed transgenic plants 57 
by metabolic engineering using prenyl transferases for the production of 58 
prenyl polyphenols in tomato fruits and legume plants, respectively.  59 
Recent studies have demonstrated that prenyl flavonoids possess strong 60 
biological activity in vitro and in vivo; however, the bioavailability of prenyl 61 
flavonoids is not yet fully understood. This review focuses on how 62 
prenylation enhances the biological activity of flavonoids and moderates 63 
their bioavailability, including effects on the intestinal absorption, 64 
metabolism, and tissue distribution of flavonoids. 65 
  66 
II. Biological activities of prenyl flavonoids 67 
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The anti-oxidant activity of prenyl flavonoids has been demonstrated. 68 
For example, Stevens et al. 11 demonstrated that prenyl flavonoids extracted 69 
from hops suppressed the oxidation of low-density lipoproteins induced by 70 
peroxynitrite. Prenyl flavonoids from the roots of Sophora flavescens showed 71 
anti-oxidant activity against DPPH radicals, ABTS radical cations, and 72 
peroxy-nitrite and reactive oxygen species 12. The anti-oxidative activity of 73 
XN was also revealed in rats administered CCl4 13. Reduction of glutathione 74 
as well as increases of thiobarbituric acid reactive substances and H2O2 75 
generation were also observed in the rats administered CCl4. However, XN 76 
pre-treatment suppressed these enhancements of oxidative stress markers 77 
and also prevented the reductions of the activities of redox-related enzymes 78 
such as superoxide dismutase, catalase, glutathione peroxidase, glutathione 79 
reductase, and glutathione S-transferase in CCl4-administered rats. 80 
Prenyl flavonoids act as selective estrogen receptor modulators 14. The 81 
position of the prenyl substituent to isoflavone changes the affinity to 82 
estrogen receptor α (ERα) or ERβ; e.g., double prenylation at positions 8 and 83 
3’ of genistein showed ERβ-selective activation 15. Icariin (Fig.1), a prenyl 84 
flavanone glycoside isolated from Epimedii herba, was shown to promote the 85 
osteogenic differentiation of rat bone marrow stromal cells by activating ERα 86 
16. 87 
Prenyl flavanone isolated from Cudrania tricuspidata Bureau 17 and 88 
Artocarpus communis 18 showed anti-inflammatory effects. XN suppressed 89 
interleukin (IL)-6 production induced by lipopolysaccharide (LPS) in human 90 
THP-1 monocytes 19. XN also reduced the levels of Toll-like receptor 4 (TLR4) 91 
protein by interacting with the TLR4 co-receptor myeloid differentiation 92 
protein-2. Three prenyl flavonoids, cudraflavone B, pomiferin, and osajin, 93 
inhibited IκB-α degradation in the murine macrophage cell line J774.A1 94 
treated with LPS 20. Chemically synthesized prenylated chalcone suppressed 95 
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prostaglandin E(2) production induced by LPS in mouse macrophages 21. The 96 
anti-inflammatory effect of 8PQ was investigated in a mouse model of paw 97 
edema induced by LPS 22. Pretreatment with 8PQ (1 µM/kg body weight) for 98 
4 days significantly reduced the LPS-induced paw thickness during the 99 
experiment without any side effects noted from the 8PQ treatment. The 100 
concentration of IL-6 in the serum from 8PQ-pretreated mice induced with 101 
LPS was lower than that of the mice treated with LPS alone. 102 
Several studies have also demonstrated other biological activities of 103 
prenyl flavonoids, such as anti-cancer 23-24, anti-bacterial 25, anti-virus 26, and 104 
anti-phospholipase phosphorylation 27 activities.  105 
 106 
III. Prenylation enhances the biological activities of flavonoids  107 
Recently, there has been much research focus on the biological activities 108 
of prenyl flavonoids, which are stronger than those of non-prenyl flavonoids 109 
(Table 1). 110 
The prenylation of flavonoids was shown to enhance the inhibitory 111 
effects of flavonoids on some enzymatic activities. For example, prenyl 112 
flavonoids from Sophora flavescens inhibited tyrosinase activity 28-29. The 113 
tyrosinase inhibitory activity of luteolin was increased by prenylation at the 114 
3-position of luteolin 30. Prenylation at the 6-position of apigenin also 115 
enhanced the inhibitory effect on melanin biosynthesis in B16 melanoma 116 
cells 31. Moreover, an increase in the length of prenylation to quercetin, 117 
genistein, and chalcone resulted in enhancement of an inhibitory effect of 118 
parent polyphenols on α-glucosidase activity 32. The prenyl chain might 119 
interact with the active site of α-glucosidase to exert an inhibitory effect. 120 
Certain flavonoids act as inhibitors of mitogen-activated protein kinase 121 
(MAPK). Prenylation to quercetin at the 8-position (8PQ) enhanced the 122 
inhibitory effect of quercetin on SEK1-JNK1/2 phosphorylation and 123 
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MEK1/2-ERK1/2 phosphorylation induced by LPS in mouse LAW264.7 124 
macrophages 22. Hisanaga et al. 22 further suggested that 8PQ showed a 125 
stronger interaction with SEK1 and MEK1 than with quercetin to inhibit the 126 
activities of these kinases. 127 
Flavonoids with prenyl groups improved the antioxidant activity in 128 
HepG2 cells 33. Kazinol E, which has three prenyl groups and a catechol 129 
structure, had a greater suppressive effect on oxidative stress than other 130 
kazinols harboring only a few or no prenyl groups. By contrast, Hošek et al. 131 
20 suggested that the catechol moiety in prenyl flavonoids is crucial for the 132 
anti-oxidative activity in the murine macrophage cell line J774.A1. Taken 133 
together, these findings suggest that the prenyl group might not improve the 134 
anti-oxidative activity itself but would instead contribute to the interaction 135 
at the target site (biomembrane and/or protein) to reveal the effect due to its 136 
elevation of hydrophobicity. 137 
8PN and 6-(1,1-dimethylallyl)naringenin showed stronger estrogenic 138 
activity than the parent compound naringenin in MCF-7 cells 34. It was 139 
further demonstrated that prenyl chains interact with a hydrophobic pocket 140 
in the estrogen receptors using an in silico modeling experiment 35. 8PN can 141 
modulate physiological responses in hormone-responsive cells 36, and  has a 142 
stronger effect on osteoblast differentiation and osteogenic function in 143 
cultured rat calvarial osteoblasts. In addition, induction of apoptosis of 144 
mature osteoclasts by 8PN was greater than that observed by naringenin. 145 
8PN has also been shown to exert beneficial effects on muscle 146 
maintenance. Our study demonstrated that 8PN improved recovery from 147 
muscle atrophy induced by immobilization 37. Ankle immobilization was used 148 
to induce disuse muscle atrophy in mice, and then 8PN feeding was started. 149 
At 20 days into the recovery period, the weight of the skeletal muscle from 150 
the 8PN-fed group was higher than that from the control group. 8PN 151 
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maintained the level of Akt phosphorylation during the recovery period, but 152 
did not increase the serum insulin-like growth factor 1 (IGF-1) concentration. 153 
In addition, a cultured cell study clearly indicated that 8PN activated the 154 
PI3K/Akt/P70S6K1 phosphorylation pathway, which promotes protein 155 
synthesis in the skeletal muscle. This activation was diminished by 156 
fulvestrant, an inhibitor of estrogen receptors. In addition, 8PN was shown 157 
to promote muscle recovery from disuse muscle atrophy in ovariectomized 158 
female mice, which was also observed in ovariectomized female mice with 159 
pellets releasing 17β-estradiol. These data suggest that activation of muscle 160 
recovery by 8PN is associated with its estrogenic activity. Another study 161 
demonstrated that the suppressive effect of 8PN on disuse muscle atrophy 162 
was related to the significant accumulation of 8PN in the skeletal muscle of  163 
mice 38. The sciatic nerve in the leg of each mouse was cut to induce 164 
immobilization for the development of disuse muscle atrophy in the 165 
gastrocnemius muscle (i.e., denervation). This muscle atrophy was 166 
completely suppressed by the pre-intake of 8PN or hops (an 8PN and its  167 
structure-related prenyl flavonoids supplier) for 14 days. The suppressive 168 
effect of 8PN was not accompanied by changes in the water and protein 169 
proportions in the muscle. In addition, 8PN did not affect the weight of the  170 
normal muscle. Although suppression of the IGF-1/mTOR/Akt pathway by 171 
denervation resulted in the induction of atrogin-1, a muscle atrophy-specific 172 
ubiquitin ligase, 8PN supplementation completely suppressed atrogin-1 173 
expression in the denervated muscle. On the other hand, feeding of 174 
naringenin over the same period had no effect on the atrophy. These results 175 
clarified that prenylation provides naringenin with the ability to prevent 176 
disuse muscle atrophy. Tissue accumulation in the gastrocnemius muscle 177 
and the plasma concentration of 8PN in mice were analyzed and compared to 178 
those of naringenin. The total amounts of 8PN (including both aglycones and 179 
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their conjugated metabolites) was 2.26–6.44 nmol/g tissue 38 (a 180 
representative result is shown in Fig. 2). This level was approximately 181 
10-fold higher than that of naringenin under the same experimental 182 
condition. 8PN aglycone was also detected in the gastrocnemius muscle, 183 
although no naringenin aglycone was detected. Higher accumulation of 8PN 184 
in the gastrocnemius muscle is likely one of the main reasons why 8PN but 185 
not naringenin exerted a preventive effect on disuse muscle atrophy. 186 
Therefore, the increment of accumulation of flavonoids in the target tissue by 187 
prenylation may be the critical factor for enhancement of the in vivo 188 
biological activity of flavonoids by prenylation. 189 
 190 
IV. Bioavailability: absorption, metabolism, and tissue distribution 191 
The biological activity of dietary flavonoids varies depending on their 192 
bioavailability, including absorption, metabolism, and tissue distribution. 193 
Studies related to the bioavailability of flavonoids have mainly been 194 
conducted using non-prenylated flavonoids with a sugar moiety or its 195 
aglycone. The sugar moiety of glucosylated flavonoids is removed during 196 
absorption in enterocytes 39. Mullen et al. 40 demonstrated that glucuronic 197 
acid, sulfate, acetyl, glutathione, or methyl groups are attached to flavonoids 198 
by phase-II metabolism in enterocytes to facilitate an increment in 199 
hydrophilicity for entering the blood circulation. Some of these metabolites 200 
have also been detected in the lymph circulation 41. Since the metabolites of 201 
flavonoids do not show an organ- or tissue-specific distribution in the body, 202 
they are found in various organs and tissues such as the liver, kidney, brain, 203 
lung, heart, skin, and muscle 42-43. ATP-binding cassette (ABC) transporters, 204 
including multidrug-resistant protein 2, breast cancer-resistant protein, and 205 
P-glycoprotein regulate the excretion of flavonoids from tissue-constituting 206 
cells 44-46. Here, we have attempted to provide an overview of the existing 207 
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information on the bioavailability of prenyl flavonoids, including their 208 
absorption, metabolism, and tissue distribution, in mammals, including 209 
humans. This information should be useful for developing functional foods 210 
containing prenyl flavonoids.  211 
 212 
Absorption of prenyl flavonoids 213 
Aoki et al. 47 demonstrated the pharmacokinetic properties of glabridin, 214 
an isoflavane with cyclization of a prenyl chain termed pyran (Fig. 1), in 215 
humans. The maximum concentration of glabridin in plasma was reached at 216 
4 h after administration of a single dose of licorice oil containing glabridin 47. 217 
Although glabridin disappeared from the plasma within a few days after the 218 
single dose, continuous administration of the same dose of licorice oil for 2 219 
weeks resulted in a steady-state plasma concentration of glabridin 47. In a 220 
clinical study, volunteers consumed a hop supplement containing 2.04 mg 221 
XN, 1.20 mg IX, and 0.1 mg 8PN three times per day for 5 days 48. The 222 
concentrations of XN and IX were determined to be 0.72–17.65 nM and 3.30–223 
31.50 nM, respectively, in hydrolyzed serum 48. LeeCole et al. 49 further 224 
demonstrated that IX, 8PN, and 6PN were detected as metabolites of XN 225 
after the oral intake of XN. The plasma concentration of these metabolites 226 
after single ingestion of XN showed two maximal peaks in the time–227 
concentration curve 50. The second peak, which was detected at 228 
approximately 5 h after ingestion, may have been due to the enterohepatic 229 
circulation 50. 8PN showed a third peak at 24 h after ingestion, which was 230 
likely derived from further complicated metabolites generating the 231 
enterohepatic circulation. 232 
 233 
Metabolic transformation of prenyl flavonoids via drug metabolism 234 
enzymes 235 
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The clinical studies described above demonstrated that glucuronide was 236 
the most abundant metabolite in both the plasma and urine. In addition, 237 
phase-I enzymes also contribute to the metabolism of prenyl flavonoids, 238 
accounting for approximately 10% of the total metabolites 48. These 239 
metabolic reactions occurring during absorption and circulation were also 240 
clarified in rodent or in vitro experiments. Icariin, a prenyl flavonoid 241 
glucoside in Epimedium spp., undergoes hydrolysis during enterohepatic 242 
circulation, resulting in the formation of an aglycone, icarinoside II 51. 243 
Lactase phlorizin hydrolase (LPH) and β-glucosidase would hydrolyze the 244 
Epimedium flavonoids such as icariin to aglycone. Rodent studies also 245 
demonstrated that glucuronide conjugation was identified as a major 246 
metabolic event after the oral ingestion of prenyl flavonoids derived from 247 
Epimedium, licorice, or hops 52-54. A cell culture study further investigated 248 
the hepatic and intestinal metabolism of 8PN 55. 8PN showed passive 249 
diffusion during absorption to Caco-2 cells, a model of enterocytes. 8PN 250 
underwent phase-II metabolism in Caco-2 cells, with approximately 54% and 251 
3% of the 8PN treated to the cells ultimately being converted to glucuronides 252 
and sulfates, respectively. The incubation of 8PN with various 253 
UDP-glucuronosyl transferases indicated that the isozymes 1A1, 1A6, 1A8, 254 
and 1A9 were responsible for the glucuronidation of 8PN. Indeed, this author 255 
detected not only the 7-O-glucuronide of 8PN but also the cis- and trans-8PN 256 
alcohols as metabolites of 8PN in hepatocytes. CYP2C19 converted 8PN to 257 
both the cis- and trans-alcohols of the prenyl side chain of 8PN, and CYP2C8 258 
was found to catalyze the formation of the trans-alcohol of the prenyl group 259 
of 8PN 56.  260 
 261 
Biotransformation of prenyl flavonoids by intestinal microflora 262 
The intestinal microflora plays an important role in the 263 
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biotransformation of prenyl flavonoids. Icariin (Fig. 1) was converted to 264 
icarinoside II, icaritin (Fig. 1), and desmethylicaritin by intestinal microflora, 265 
including Streptococcus sp., Enterococcus sp., and Blautia sp. 57. Liu et al. 58 266 
demonstrated that 8PN was generated after ingestion of XN in humans. XN 267 
was spontaneously converted to IX during heating in beer production, and 268 
then IX further underwent enzymatic O-demethylation to 8PN by CYP1A2 56 269 
or via intestinal microflora metabolism (Fig. 3) 59-60. Eubacterium limosum 270 
resulted in 90% conversion of IX to 8PN in vitro with pure incubation 61. 8PN 271 
production in humans exhibited individual variation depending on the 272 
intestinal microflora composition. Possemiers et al. 59 carried out the in vitro 273 
incubation of 51 fecal samples from female volunteers with IX, and classified 274 
the ability of 8PN production as poor (32 of 51), moderate (11 of 51), and 275 
strong (8 of 51) based on the level of 8PN production from IX.  276 
 277 
Tissue distribution of prenyl flavonoids 278 
A few studies have evaluated the tissue distribution of prenyl flavonoids in 279 
rodent animal models 62-64. The intraperitoneal injection of icariin to mice 280 
resulted in icariin distribution into the spleen, liver, lung, kidney, heart, and 281 
brain 64. The maximum concentrations of icariin in each tissue was in the 282 
order spleen > lung > liver > kidney > heart > brain. However, with oral 283 
injection of icaritin to rats, the maximum concentrations of icaritin in each 284 
tissue showed a different order: liver > spleen > muscle > lung > kidney > 285 
heart 63. The maximum concentration of icaritin aglycone in each tissue was 286 
detected within 1 h. The liver showed the highest accumulation of icaritin 287 
aglycone, whereas most of the icaritin glucuronide was detected in the 288 
kidney 63. These results imply that icaritin aglycone could undergo 289 
glucuronidation in the liver and then the glucuronides would excrete into the 290 
urine. 4-Hydroxyderricin, a prenyl chalcone from Angelica keiskei, was 291 
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found to be distributed in the liver, kidney, spleen, skeletal muscle, and 292 
adipose tissue after single ingestion in mice 62. A higher amount of 293 
4-hydroxyderricin was detected in the adipose tissue than the other tissues. 294 
Thus, the adipose tissue could be the storage site of prenyl flavonoids 295 
because prenyl flavonoids are more hydrophobic than their parent flavonoids. 296 
Only one clinical study was carried out by Bolca et al. 48, who demonstrated 297 
that XN and IX were detected in the breast tissue after hops 298 
supplementation in women.  299 
 300 
Prenylation reduces intestinal absorption and enhances tissue 301 
accumulation of dietary flavonoids 302 
The author’s group carried out a study to clarify the effect of prenylation 303 
on the bioavailability of flavonoids, since there were few studies related to 304 
the effect of prenylation on the bioavailability of flavonoids compared with 305 
studies on their biological activities 65. 8PQ was applied for this study 306 
because the bioavailability, metabolism, and tissue distribution properties of 307 
quercetin are well known. We determined the tissue distribution of 8PQ in 308 
mice fed 8PQ for 2 weeks (Fig. 2; note that the data were modified from the 309 
previous report 65). The tissue accumulation of the subtotal of 8PQ and its 310 
metabolites in the liver and kidneys was at least 10 times higher than that of 311 
the parent quercetin. However, the plasma and lymph concentrations of 8PQ 312 
after single ingestion, as an index of intestinal absorption, were lower than 313 
those of quercetin. Results showing the same trend were obtained from a 314 
study using 8PN and naringenin 38. Konishi et al. 66 also demonstrated that 315 
prenylation to p-coumaric acid (artepillinC) lowered the intestinal 316 
absorption compared with the parent p-coumaric acid. Moreover, an 317 
experiment on intestinal permeability using Caco-2 cells demonstrated that 318 
8PQ permeated to the basolateral side at an extremely low level, although 319 
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the cellular uptake of 8PQ in Caco-2 cells was higher than that of quercetin 320 
65. This result is supported by a study showing that XN was hardly excreted 321 
from Caco-2 cells because of the trap created by cytosolic proteins in the cells 322 
67. Therefore, it is likely that prenyl flavonoids accumulated at a higher level 323 
than the parent flavonoids despite their lower intestinal absorption. In order 324 
to clarify the reason for this apparent contradiction, an experiment was 325 
carried out on the uptake into murine skeletal muscle C2C12 myoblast cells 326 
as an organ model. The results showed that the cellular uptake of 8PQ and 327 
8PN was up to 10-times greater than that of the parent flavonoids; moreover, 328 
the accumulation persisted for a longer time than that of the non-prenylated 329 
forms. In addition, 8PQ, unlike quercetin, is hardly excreted outside the cell 330 
at all via the ABC transporter. Although glucuronidation to prenyl flavonoids 331 
is necessary for their excretion from cells, an increase of the number of 332 
prenyl groups will decrease the rate of glucuronidation 68. This could be one 333 
of the reasons explaining why prenyl flavonoids do not readily excrete from 334 
tissues. Consequently, prenylation enhances the tissue accumulation of 335 
flavonoids by modulating the balance between the absorption and excretion 336 
of flavonoids in tissue-constituting cells. 337 
 338 
V. Conclusion and future perspectives 339 
Proposed scheme of the accumulation of prenyl flavonoids in the tissues 340 
to exert strong biological activity in vivo is shown in Fig. 4. Prenylation 341 
lowers the transport of flavonoids from enterocytes to the internal circulation, 342 
elevates its incorporation from the circulation to tissue-constituting cells, 343 
and slows its efflux from tissue-constituting cells. Prenylation facilitates the 344 
accumulation in target tissues to exert strong biological activity in the case 345 
of continuous, long-term dietary intake. 346 
Prenyl flavonoids will be used as components of functional foods because 347 
Mukai   Current status of prenyl flavonoids 
of their potent biological activity. For this purpose, it is necessary to verify 348 
the biological activity based on the bioavailability in clinical studies. 349 
Differences in metabolism between individuals, which were notably observed 350 
in the study of microflora, may influence the biological activity. The rodent 351 
study implied that prenyl flavonoids are cleared from the tissues within a 352 
few days after a single dose, indicating that they could not be stored in vivo. 353 
However, dramatically high accumulation of prenyl flavonoids in several 354 
tissues after long-term ingestion was observed. Since this phenomenon 355 
raises concerns of the potential side effects of prenyl flavonoids, it is 356 
necessary to investigate the clearance of prenyl flavonoids from the tissues 357 
into the urine and feces after long-term ingestion. Clarification of the 358 
balance between absorption and excretion would help to determine how 359 
much and for how long prenyl flavonoids should be taken for exerting a 360 
beneficial effect for human health without any harmful side effects. 361 
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Table 1. Prenylation enhances biological activities of parent flavonoids 617 
Position Parent flavonoid Enhanced activity Experimental model Ref 
3-prenyl luteolin Inhibition of tyrosinase  In vitro 30 
6-prenyl apigenin Inhibition of melanin byosynthesis B16 melanoma cells 31 
5’-prenyl chalcone 
Inhibition of α-glucosidase In vitro 32 
8-prenyl quercetin 
8-prenyl quercetin Inhibition of MAPKs LAW264.7 cells 22 
8 or 6-prenyl naringenin Estrogenic activity MCF-7 cells 34-35 
8-prenyl naringenin Bone maintenance Calvarial osteoblasts 36 
8-prenyl naringenin Muscle maintenance C57BL6 mice 38 
 618 
619 
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Figure legends 620 
Fig.1 Chemical structures of prenyl flavonoids in edible plants. 621 
 622 
Fig.2 High accumulation of prenyl flavonoids in the tissues. Mukai et al. 38, 65 623 
demonstrated higher tissue accumulation of prenyl flavonoids by comparison 624 
with parent flavonoids. Mice were fed each flavonoid mixed in a diet for more 625 
than 2 weeks, and the concentrations were analyzed by high-performance 626 
liquid chromatography. (A) Accumulation of 8PN and naringenin in the 627 
gastronomic muscle 38, (B) 8PQ and quercetin in the liver and kidney 65. Data 628 
are modified from previous reports 38, 65. Data represent the mean ± S.E (n = 629 
4). Asterisks indicate significant differences analyzed by two-sided Student’s 630 
t-test (p < 0.05).  631 
 632 
Fig.3 Conversion of XN to 8PN 56, 59-60 633 
 634 
Fig.4 Prenylation enhances the biological activity of dietary flavonoids by 635 
increasing their bioaccumulation. 636 
 637 
Caption for graphical abstract 638 
 This review provides current knowledge of how prenylation influences the 639 
biological activity and bioavailability of dietary flavonoids. 640 
 641 





